Goodwin Procter advised the underwriters on the deal.Genenta Science S.p.A.’s (Nasdaq: GNTA) announced its upsized initial public offering, making history as the first Italian biotech to be…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
